AI assistant
Sending…
TScan Therapeutics, Inc. — Director's Dealing 2021
Jul 16, 2021
34191_dirs_2021-07-15_e03b9b81-ad8a-44d9-b9b5-8cfc4d0909db.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: TScan Therapeutics, Inc. (TCRX)
CIK: 0001783328
Period of Report: 2021-07-15
Reporting Person: Biggar Stephen R (Director)
More from TScan Therapeutics, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
May 22
Interim / Quarterly Report
2026
May 6
Earnings Release
2026
May 6
Annual Report
2026
Apr 17
Proxy Solicitation & Information Statement
2026
Apr 17
Board/Management Information
2026
Apr 2
Annual Report
2026
Mar 4
Earnings Release
2026
Mar 4
Director's Dealing
2026
Jan 22
Director's Dealing
2026
Jan 22